home / United States / Sangamo Therapeutics

Sangamo Therapeutics Market Cap

$0.24 B

+1.04 M

NASDAQ:SGMO · January 22, 2025

Share price

$1.13

Enterprise Value

$0.22 B

Change (1-Year)

142.2%

Global Rank

#6946

Country Rank

#2720

Regions

USA

Market cap

As of January 22, 2025, Sangamo Therapeutics (SGMO) has a market cap of $0.24 billion USD. According to our data, Sangamo Therapeutics is ranked No.6946 in global market value.

Sector Rank:

Biotech #447 Pharmaceuticals #409 Genomics #31 Gene therapy #16

SGMO Market Capitalization Growth

30D Growth:

-56.4%

1 Years Growth:

142.2%

3 Years Growth:

-81.6%

5 Years Growth:

-86.4%

10 Years Growth:

-91.9%

15 Years Growth:

-79.8%

20 Years Growth:

-77.1%

Total Growth:

-92%

Sangamo Therapeutics Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Sangamo Therapeutics Market Cap CAGR Chart

Sangamo Therapeutics Market Cap History 2000 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$0.24 B	11.27%
Dec 31, 2024	$0.21 B	88.89%
Dec 29, 2023	$0.11 B	-82.80%
Dec 30, 2022	$0.66 B	-58.13%
Dec 31, 2021	$1.56 B	-51.95%
Dec 31, 2020	$3.26 B	86.50%
Dec 31, 2019	$1.75 B	-27.09%
Dec 31, 2018	$2.40 B	-30.00%
Dec 29, 2017	$3.42 B	437.70%
Dec 30, 2016	$0.64 B	-66.59%
Dec 31, 2015	$1.90 B	-39.97%
Dec 31, 2014	$3.17 B	9.50%
Dec 31, 2013	$2.90 B	131.11%
Dec 31, 2012	$1.25 B	111.62%
Dec 30, 2011	$0.59 B	-57.23%
Dec 31, 2010	$1.39 B	12.16%
Dec 31, 2009	$1.24 B	70.11%
Dec 31, 2008	$0.73 B	-73.27%
Dec 31, 2007	$2.72 B	97.27%
Dec 29, 2006	$1.38 B	63.77%
Dec 30, 2005	$0.84 B	-32.83%
Dec 31, 2004	$1.25 B	9.69%
Dec 31, 2003	$1.14 B	81.73%
Dec 31, 2002	$0.63 B	-67.77%
Dec 31, 2001	$1.95 B	-52.10%
Dec 29, 2000	$4.07 B	100%

Similar Companies to Sangamo Therapeutics

Name	Market Cap	Market cap difference	Regions
CRISPR Therapeutics CRSP	$3.77 B	-0.000 M	Switzerland
Editas Medicine EDIT	$0.11 B	0.000 M	USA
Intellia Therapeutics NTLA	$1.11 B	-0.000 M	USA
Beam Therapeutics BEAM	$2.19 B	0.000 M	USA
Moderna MRNA	$14.82 B	-0.000 M	USA
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA
Vertex Pharmaceuticals VRTX	$110.22 B	0.001 M	USA
Gilead Sciences GILD	$115.95 B	0.002 M	USA
Amgen AMGN	$146.98 B	0.004 M	USA
Illumina ILMN	$22.26 B	0.000 M	USA
BioMarin Pharmaceutical BMRN	$11.82 B	0.000 M	USA
Alnylam Pharmaceuticals ALNY	$34.38 B	-0.000 M	USA
Sangamo Therapeutics SGMO	$0.24 B	0.000 M	USA
10x Genomics TXG	$1.97 B	0.229 B	USA
Novartis NVS	$196.25 B	0.003 M	Switzerland

About Sangamo Therapeutics Inc.

Name

Sangamo Therapeutics, Inc.

Website

https://www.sangamo.com

Headquarters

Richmond,CA

symbol

SGMO

CURRENCY

USD

country

United States

fullTimeEmployees

405

exchange

NCM

firstTradeDateEpochUtc

2000/04/06

SGMO Market Cap Formula

Market Cap	=	SGMO Stock Price	*	SGMO Shares Outstanding
	=	$1.13	*	0.21 B
	=	$0.24 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe